Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties
- 1 May 2006
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 32 (3), 214-228
- https://doi.org/10.1016/j.ctrv.2005.12.011
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly scheduleAnnals of Oncology, 2004
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Percutaneous radiofrequency ablation of liver metastases in potential candidates for resectionCancer, 2003
- Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver ResectabilityAnnals of Surgical Oncology, 2001
- Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastasesBritish Journal of Surgery, 2001
- Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver TumorsAnnals of Surgery, 2000
- CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1999
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994